Zhang, Y.; Liu, X.; Wu, J.; Zhang, X.; Wei, F.; Li, L.; Li, H.; Wang, X.; Wang, B.; Wu, W.;
et al. Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting System. Pharmaceuticals 2025, 18, 1062.
https://doi.org/10.3390/ph18071062
AMA Style
Zhang Y, Liu X, Wu J, Zhang X, Wei F, Li L, Li H, Wang X, Wang B, Wu W,
et al. Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting System. Pharmaceuticals. 2025; 18(7):1062.
https://doi.org/10.3390/ph18071062
Chicago/Turabian Style
Zhang, Yi, Xiaoyu Liu, Jianru Wu, Xuening Zhang, Fenfang Wei, Limin Li, Hongqiao Li, Xinru Wang, Bei Wang, Wenyu Wu,
and et al. 2025. "Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting System" Pharmaceuticals 18, no. 7: 1062.
https://doi.org/10.3390/ph18071062
APA Style
Zhang, Y., Liu, X., Wu, J., Zhang, X., Wei, F., Li, L., Li, H., Wang, X., Wang, B., Wu, W., & Hong, X.
(2025). Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting System. Pharmaceuticals, 18(7), 1062.
https://doi.org/10.3390/ph18071062
